Ingen CEO National Televised Broadcast on The Money Show
Online, April 30, 2010 (Newswire.com) - Ingen Technologies, Inc. (Pink Sheets: IGNT.PK), a leading manufacturer of respiratory medical devices, recently announced that CEO, Scott Sand, will debuted various new products in their medical product line including Oxyview, The Smart Nasal Cannula and the new Ingen Pulse Oximeter at the May 11th-2010 televised Las Vegas Money Show with host Steve Crowley from the Money Channel's renowned American Scene broadcast. Ingen Technologies projects that the SMART Nasal Cannula will bring $10M in revenues, and the new INGEN Pulse Oximeter an additional $1M in revenues during 2010, and reach $200M over the next 5 years.
"Ingen is on the verge of tremendous growth, after enduring a number of regulatory and economic obstacles. In the face of economic headwinds, the company obtained both FDA and ISO Certification and launched several new and inspiring medical products in the respiratory market. As a result of this success, we have attracted many investors and new shareholders." Stated Mr. Sand in a recent statement to the shareholders. He further stated; " Ingen has developed a global perspective on the markets in which we compete, inclusive of a thorough market study, securing valuable intellectual property, properly registering our products with the FDA and securing ISO 13485 Certification, CE Mark and distribution partners in order to comply with the world markets for distribution of our medical products".
Ingen's recent successes and changes came during a restructuring in order to align incentives with that of its shareholders. The company is keenly focused on growth, open communication, and leadership by example, as it works diligently to expand its sales and deliver shareholder value.
"The Money Channel has been a very good investment for Ingen and its shareholders to discuss current events and the future of this company. It is a valuable tool that offers shareholders and new investors current information about what we have accomplished and where the company is headed. There is no question that we have strong financial backing to execute our share buy-back program scheduled in June-2010, along with a very strong and active stock that is now demonstrating its potential. This new restructure is designed to take the company on to the Amex at a stock price of greater than $5.00 per share.", Stated Scott Sand, CEO and Chairman of the Board.
For more information visit at: http://www.ingen-tech.com
Share:
Tags: high flow nasal cannula, medical cannula, oxygen medical supplies, oxygen nasal cannula